Strauss Borrelli PLLC, a leading data breach law firm, is investigating Grifols USA, LLC (“Grifols”) regarding its recent data breach. The Grifols data breach involved sensitive protected health information belonging to an undetermined number of individuals.
ABOUT GRIFOLS USA, LLC:
Grifols is a global healthcare and pharmaceutical company based in Spain. Founded in 1909, Grifols develops, produces and provides innovative healthcare services and solutions in more than 110 countries.2 A leader in essential plasma-derived medicines and transfusion medicine, Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases.2 Headquartered in Barcelona, Spain, Grifols has a workforce of over 23,000 employees in more than 30 countries and regions.2 Based in Los Angeles, Grifols USA was established in 2003 to cover the U.S. market where it offers a comprehensive portfolio of Grifols products and services.3
WHAT HAPPENED?
Recently, Grifols was informed that its business partner, Cencora, Inc., and its Lash Group affiliate had experienced a data breach in which sensitive protected health information belonging to Grifols customers in its systems may have been accessed and acquired. Through its investigation, Cencora determined that an unauthorized actor gained access to this sensitive information on February 21, 2024. On May 22, 2024, Cencora began notifying individuals whose information may have been impacted. The type of information potentially exposed includes:
- Name
- Date of birth
- Address
- Medical information (e.g., health diagnosis, and/or medications and prescriptions)
If you received a breach notification letter from Grifols USA, LLC, Cencora, Inc., or The Lash Group:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
